The carniofacial phenotype of fibrodysplasia ossificans progressiva

  • Frederick S. Kaplan
  • Dylan Hume
  • Anders Westermark
  • Eileen M. Shore
Fibrodysplasia Ossificans Progressiva


Patients with fibrodysplasia ossificans progressiva (FOP) develop a craniofacial phenotype characterized most notably by mandibular hypoplasia. Other less well-defined features of FOP include invol vement of the joints, muscles, and associated fascia of the head and neck. Although absent at birth, the craniofacial phnotype generally emerges during the second decade of life. The cranofacial features of FOP may provide important insight into underlying molecular signaling pathways involved in the pathogenesis of the disease.

Key Words

Fibrodysplasia ossificans progressiva (FOP) craniofacial BMP4 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Connor JM, Evans DAP. 1982 Fibrodysplasia ossificans progressiva (FOP). The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64:76–83.PubMedGoogle Scholar
  2. 2.
    Cohen RB, Hahn GV, Tabas J, et al. 1993 The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 75:215–219.PubMedGoogle Scholar
  3. 3.
    Kaplan FS, Shore EM, Connor JM. 2002 Fibrodysplasia ossificans progressiva. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd Ed. Wiley-Liss; John Wiley & Sons., New York, pp. 827–840.Google Scholar
  4. 4.
    Renton P, Parkin SR, Stamp TCB, 1982 Abnormal temporomandibular joints in fibrodysplasia ossificans progressiva. Br J Oral Surg 20:31–38.PubMedCrossRefGoogle Scholar
  5. 5.
    Chichareon V, Arporkaeklong P, Donsakul N. 1999 Fibrodysplasia ossificans progressiva and associated osteochondroma of the coronoid process in a child. Plastic Reconstructive Surg 103:1238–1243.CrossRefGoogle Scholar
  6. 6.
    Connor JM, Smith R. 1982 The cervical spine in fibrodysplasia ossificans progressiva (FOP). Br J Radiol 55:492–496.PubMedCrossRefGoogle Scholar
  7. 7.
    Schaffer AA, Kaplan FS, Tracy MR, et al. 2005 Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine 30:1379–1385.PubMedCrossRefGoogle Scholar
  8. 8.
    Levy CE, Lash AT, Janoff HB, Kaplan FS. 1999 Conductive hearing loss in individuals with fibrodysplasia ossificans progressive. Am J Audiol 8:29–33.PubMedCrossRefGoogle Scholar
  9. 9.
    Luchetti W, Cohen RB, Hahn GV, et al. 1996 Severe restriction in jaw movement after route injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:21–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Janoff HB, Zasloff MA, Kaplan FS. 1996 Submandibular swelling in patients with fibrodysplasia ossificans progressiva. Otolaryngol Head Neck Surg 114:599–604.PubMedCrossRefGoogle Scholar
  11. 11.
    Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. 2004 Craniofacial defects in mice lacking BMP Type 1 receptor Alk2 in neural crest cells. Mechanisms Dev 121: 173–182.PubMedCrossRefGoogle Scholar
  12. 12.
    Gerlach LM, Hutson MR, Germiller JA, Nguyen-Luu D, Victor JC, Barald KF. 2000 Addition of the BMP4 antagonist, noggin, disrupts avian inner ear development. Development 127:45–54.PubMedGoogle Scholar
  13. 13.
    Gong SG, Guo C. 2003 BMP4 gene is expressed at the putative site of fusion in the midfacial region. Differentiation 71: 228–236.PubMedCrossRefGoogle Scholar
  14. 14.
    Shum L, Wang X, Kane AA, Nuckolls GH. 2003 BMP4 promotes chondrocyte proliferation and hypertrophy in the endochondral cranial base. Int J Dev Biol 47:423–431.PubMedGoogle Scholar
  15. 15.
    Stottman RW, Anderson RM, Klingensmith J. 2001 The BMP antagonists chordin and noggin have essential but redundant role in mouse mandibular outgrowth. Dev Biol 240:457–473.CrossRefGoogle Scholar
  16. 16.
    Hammond P, Hutton TJ, Allanson JE, et al. 2004 3D Analysis of facial morphometry. Am J Med Genetics 126A:339–348.CrossRefGoogle Scholar
  17. 17.
    Ward RE, Jamison PL, Allanson JE. 2000 Quantitative approach to identifying abnormal variation in the human face exemplified by a study of 278 individuals with five craniofacial syndromes. Am J Med Genet 91:8–17.PubMedCrossRefGoogle Scholar
  18. 18.
    Ward RE, Jamison PL, Farkas LG. 1998 Cramiofacial variability index: a simple measure of normal and abnormal variation in the head and face. Am J Med Genet 80:232–240.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Frederick S. Kaplan
    • 5
    • 1
    • 3
  • Dylan Hume
    • 3
  • Anders Westermark
    • 4
  • Eileen M. Shore
    • 5
    • 2
    • 3
  1. 1.Department of MedicineThe University of Pennsylvania School of MedicinePhiladelphia
  2. 2.Department of GeneticsThe University of Pennsylvania School of MedicinePhiladelphia
  3. 3.The Center for Research in FOP and Related DisondersThe University of Pennsylvania School of MedicinePhiladelphia
  4. 4.Department of Maxillofacial SurgeryKarolinska University HospitalStockholmSweden
  5. 5.Deparment of Orthopaedic SurgeryThe University of Pennsylvania School of MedicinePhiladelphia

Personalised recommendations